503 related articles for article (PubMed ID: 3927648)
1. Evidence of a circulating growth hormone stimulating factor other than growth hormone releasing hormone in a patient with pituitary tumour and acromegaly.
Hulting AL; Wersäll J; Werner S
Acta Endocrinol (Copenh); 1985 Jul; 109(3):289-94. PubMed ID: 3927648
[TBL] [Abstract][Full Text] [Related]
2. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
3. Secretion of glycoprotein hormone alpha-subunit by pituitary tumors.
Ishibashi M; Yamaji T; Takaku F; Teramoto A; Fukushima T
J Clin Endocrinol Metab; 1987 Jun; 64(6):1187-93. PubMed ID: 2437140
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein hormone alpha-subunit response to growth hormone (GH)-releasing hormone in patients with active acromegaly. Evidence for alpha-subunit and GH coexistence in the same tumoral cell.
Beck-Peccoz P; Bassetti M; Spada A; Medri G; Arosio M; Giannattasio G; Faglia G
J Clin Endocrinol Metab; 1985 Sep; 61(3):541-6. PubMed ID: 2410443
[TBL] [Abstract][Full Text] [Related]
5. The interrelationship between the effects of somatostatin and human pancreatic growth hormone-releasing factor on growth hormone release by cultured pituitary tumor cells from patients with acromegaly.
Lamberts SW; Verleun T; Oosterom R
J Clin Endocrinol Metab; 1984 Feb; 58(2):250-4. PubMed ID: 6141175
[TBL] [Abstract][Full Text] [Related]
6. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
[TBL] [Abstract][Full Text] [Related]
7. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K
J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540
[TBL] [Abstract][Full Text] [Related]
8. Glycoprotein hormone alpha-subunit and prolactin release by cultured pituitary adenoma cells from acromegalic patients: correlation with GH release.
Hofland LJ; van Koetsveld PM; Verleun TM; Lamberts SW
Clin Endocrinol (Oxf); 1989 Jun; 30(6):601-11. PubMed ID: 2512040
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone and prolactin in tissue culture of pituitary adenoma.
Demura R; Kubo O; Odagiri E; Nomura K; Yamaguchi H
Endocrinol Jpn; 1977 Jun; 24(3):259-64. PubMed ID: 913336
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment with bromocriptine of a plurihormonal pituitary adenoma secreting thyrotropin, growth hormone and prolactin.
Shimatsu A; Murabe H; Nakamura Y; Mizuta H; Ihara C; Nakao K
Endocr J; 1999 Feb; 46(1):159-65. PubMed ID: 10426581
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone-releasing factor does not stimulate phosphoinositides breakdown in primary cultures of rat and human pituitary cells.
Escobar DC; Vicentini LM; Ghigo E; Ciccarelli E; Usellini L; Capella C; Cocchi D
Acta Endocrinol (Copenh); 1986 Jul; 112(3):345-50. PubMed ID: 3019052
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone-releasing factor increases serum prolactin concentrations in normal subjects and in patients with pituitary adenomas.
Serri O; Somma M; Rasio E; Brazeau P
Clin Endocrinol (Oxf); 1989 Jan; 30(1):65-75. PubMed ID: 2505955
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone releasing hormone-sensitive adenylate cyclase activity in growth hormone-producing pituitary adenoma: correlation to the response of plasma growth hormone to growth hormone releasing hormone in patients with acromegaly.
Natori S; Ikuyama S; Haji M; Ohashi M; Nawata H
Endocrinol Jpn; 1989 Apr; 36(2):229-36. PubMed ID: 2550207
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors.
Lopes MB; Gaylinn BD; Thorner MO; Stoler MH
Am J Pathol; 1997 Jun; 150(6):1885-91. PubMed ID: 9176381
[TBL] [Abstract][Full Text] [Related]
15. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
[TBL] [Abstract][Full Text] [Related]
16. Recurrent plurihormonal bimorphous pituitary adenoma producing growth hormone, thyrotropin, and prolactin.
Felix I; Asa SL; Kovacs K; Horvath E; Smyth HS
Arch Pathol Lab Med; 1994 Jan; 118(1):66-70. PubMed ID: 8285835
[TBL] [Abstract][Full Text] [Related]
17. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors.
Seo H; Refetoff S; Fang VS
Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484
[TBL] [Abstract][Full Text] [Related]
18. The expression of thyrotrophin-releasing hormone receptor 1 messenger ribonucleic acid in human pituitary adenomas.
Kim K; Arai K; Sanno N; Teramoto A; Shibasaki T
Clin Endocrinol (Oxf); 2001 Mar; 54(3):309-16. PubMed ID: 11298082
[TBL] [Abstract][Full Text] [Related]
19. Lack of desensitization of adenomatous somatotrophs to growth-hormone releasing hormone in acromegaly.
Spada A; Elahi FR; Arosio M; Sartorio A; Guglielmino L; Vallar L; Faglia G
J Clin Endocrinol Metab; 1987 Mar; 64(3):585-91. PubMed ID: 3102543
[TBL] [Abstract][Full Text] [Related]
20. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
